<DOC>
	<DOC>NCT00785083</DOC>
	<brief_summary>This study will evaluate the effect of FTY720 on the lung function of patients with moderate asthma</brief_summary>
	<brief_title>A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Forced Expiratory Volume in 1 second of at least 60% History of asthma for at least 6 months Current use of shortacting beta agonists, inhaled longacting beta agonists and inhaled corticosteroids (up to a specified dose) History of lung disease other than asthma Smokers Use of inhaled corticosteroid above specified dose Use of oral beta agonists or corticosteroids or other asthma medications Hypersensitivity to the drug Respiratory tract infections within 1 month of the study Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume</keyword>
</DOC>